Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer PatientsNCT04588805
Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study
An observational study of Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients, run by Beijing Friendship Hospital.
Trial summary
This is a multi-centered, prospective, observational study aimed at observing the Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
- How many people
- 1,217 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2020to 1 Jul 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Colorectal cancer patients prepare for radical colorectal surgery in colorectal surgery wards
Who may be able to join
- Patients in colorectal surgery ward Clinical diagnosis of colorectal cancer Prepare for radical colorectal surgery.
Who cannot join
- Patients prepare for emergency surgery Clinical diagnosis of benign colorectal disease Patients who have joined other clinic studys
About this study
Official title: Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study
This is a multi-centered, prospective, observational study aimed at observing the Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients
- Conditions
- Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
- Keywords
- Venous Thromboembolism, Colorectal Cancer
- Medical subject headings
- Venous Thromboembolism, Colorectal Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Colorectal Cancer Patients | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
ncidence Rate of Perioperiative VTE
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2020
- Study start1 Nov 2020 (estimated)
- Primary completion1 Jun 2021 (estimated)
- Study completion1 Jul 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer PatientsStudies of the same condition, open and under way.
- More trials run by Beijing Friendship HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,217 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Beijing Friendship Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zhongtao Zhang, Beijing Friendship Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04588805
- Sponsor's protocol ID
- BeijingFH ZZhang
- Status last verified
- Oct 2020
- First submitted
- 9 Oct 2020
- Last updated
- 19 Oct 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Gu ZC, Dai MF, Wei Q, Yan YD, Zheng JY, Wang GY, Wei ZQ, Jing CQ, Li YX, Zhou DB, Lin MB, He XL, Li F, Liu Q, Tu SL, Wang ZJ, Li A, Lin HW, Yao HW, Zhang ZT; CRC-VTE Investigators. Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization. Pharmacotherapy. 2024 Jul;44(7):549-557. doi: 10.1002/phar.2945. Epub 2024 Jun 17.
PubMed 38884415Wei Q, Wang Y, An YB, Yang ZY, Liu YS, Zhang X, Gu ZC, Yao HW; CRC-VTE investigators. Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial). Transl Cancer Res. 2022 May;11(5):1406-1412. doi: 10.21037/tcr-21-1860.
PubMed 35706792
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study
- ClinicalTrials.gov ID
- NCT04588805
- Acronym / sponsor ID
- BeijingFH ZZhang
- Conditions
- Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
- Keywords
- Venous Thromboembolism, Colorectal Cancer
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,217 participants (estimated)
- Lead sponsor
- Beijing Friendship HospitalUniversity, hospital or other
- Study start
- 1 Nov 2020 (estimated)
- Primary completion
- 1 Jun 2021 (estimated)
- Study completion
- 1 Jul 2021 (estimated)
- First posted
- 19 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a multi-centered, prospective, observational study aimed at observing the Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Colorectal Cancer Patients | – | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Colorectal cancer patients prepare for radical colorectal surgery in colorectal surgery wards
Key inclusion criteria (1 listed)
- Patients in colorectal surgery ward Clinical diagnosis of colorectal cancer Prepare for radical colorectal surgery.
Key exclusion criteria (1 listed)
- Patients prepare for emergency surgery Clinical diagnosis of benign colorectal disease Patients who have joined other clinic studys
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
ncidence Rate of Perioperiative VTE
Time frame: 1 month
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2020.
- Derived from this study: PubMed 38884415Gu ZC, Dai MF, Wei Q, Yan YD, Zheng JY, Wang GY, Wei ZQ, Jing CQ, Li YX, Zhou DB, Lin MB, He XL, Li F, Liu Q, Tu SL, Wang ZJ, Li A, Lin HW, Yao HW, Zhang ZT; CRC-VTE Investigators. Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization. Pharmacotherapy. 2024 Jul;44(7):549-557. doi: 10.1002/phar.2945. Epub 2024 Jun 17.
- Derived from this study: PubMed 35706792Wei Q, Wang Y, An YB, Yang ZY, Liu YS, Zhang X, Gu ZC, Yao HW; CRC-VTE investigators. Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial). Transl Cancer Res. 2022 May;11(5):1406-1412. doi: 10.21037/tcr-21-1860.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients, run by Beijing Friendship Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ncidence Rate of Perioperiative VTE (time frame: 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04588805, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2020.